Effect of high-dose-rate 192Ir source activity on late rectal bleeding after intracavitary radiation therapy for uterine cervix cancer

被引:12
|
作者
Suzuki, Osamu [1 ]
Yoshioka, Yasuo [2 ]
Isohashi, Fumiaki [2 ]
Morimoto, Masahiro [1 ]
Kotsuma, Tadayuki [2 ]
Kawaguchi, Yoshifumi [2 ]
Konishi, Koji [2 ]
Nakamura, Satoaki [1 ]
Shiomi, Hiroya [2 ]
Inoue, Takehiro [2 ]
机构
[1] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Radiat Oncol, Osaka 5378511, Japan
[2] Osaka Univ, Grad Sch Med, Dept Radiat Oncol, Osaka, Japan
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2008年 / 71卷 / 05期
关键词
high-dose-rate; cervical cancer; intracavitary radiation therapy; late morbidity; brachytherapy;
D O I
10.1016/j.ijrobp.2007.11.074
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: This retrospective study analyzed the effect of the activity of high-dose-rate (HDR) Ir-192 source on late rectal bleeding after HDR intracavitary radiotherapy (ICRT) in patients with uterine cervix cancer. Methods and Materials: One hundred thirty-two patients who underwent HDR-ICRT and external beam radiotherapy (EBRT) were analyzed. The rectal point dose in ICRTwas calculated by inserting a lead wire into the rectal lumen and summed with the whole-pelvic EBRT dose. The rectal biologic effective dose (BED) was calculated. The relationship between averaged source activity or the BED and late rectal bleeding were analyzed. Results: Three-year actuarial rectal bleeding probabilities were 46% (>= 100 Gy(3)) and 18% (<= 100 Gy(3)) respectively (p < 0.005). When patients were divided into four groups according to rectal BED (>= or <= 100 Gy(3)) and source activity (>= or <= 2.4 cGy.m(2).h(-1)), the group with both a high BED and high activity showed significantly greater probability (58% at 3 years; p < 0.005). It was noted that 2 the probability of the group with BED of 100 Gy(3) or greater was high, but that was not the case with 2.4 cGy.m(2).h(-1) or less. Conclusion: This is the first clinical report concerning the source activity effect of HDR Ir-192 on late rectal bleeding in patients undergoing HDR-ICRT. This suggests that when source activity is higher than 2.4 cGy.m(2).h(-1), ICRT should be performed with more caution not to exceed 100 Gy(3) in total. (c) 2008 Elsevier Inc.
引用
收藏
页码:1329 / 1334
页数:6
相关论文
共 39 条
  • [31] 3D CT-based high-dose-rate brachytherapy for cervical cancer: Clinical impact on late rectal bleeding and local control
    Kang, Hyun-Cheol
    Shin, Kyung Hwan
    Park, Sung-Yong
    Kim, Joo-Young
    RADIOTHERAPY AND ONCOLOGY, 2010, 97 (03) : 507 - 513
  • [32] Results of radiation therapy for uterine cervical cancer using high dose rate remote after loading system
    Ogawa, Y
    Nemoto, K
    Kakuto, Y
    Ariga, H
    Matsushita, H
    Takeda, K
    Takahashi, C
    Gallardo, B
    Richard, K
    Takai, Y
    Yamada, S
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 199 (04) : 229 - 238
  • [33] Assessing Heterogeneity Effects on Points A, B, and Organs at Risk Doses in High-dose-Rate Brachytherapy for Cervical Cancer - A Comparison of 192Ir and 60Co Sources Using Monte Carlo N-Particle 5
    Sadeghi, Mohammad Hossein
    Sina, Sedigheh
    Meigooni, Ali Soleimani
    JOURNAL OF MEDICAL PHYSICS, 2024, 49 (02) : 294 - 303
  • [34] Dosimetric comparison of 192Ir high-dose-rate brachytherapy vs. 50 kV x-rays as techniques for breast intraoperative radiation therapy: Conceptual development of image-guided intraoperative brachytherapy using a multilumen balloon applicator and in-room CT imaging
    Jones, Ryan
    Libby, Bruce
    Showalter, Shayna L.
    Brenin, David R.
    Wilson, David D.
    Schroen, Anneke
    Morris, Monica
    Reardon, Kelli A.
    Morrison, John
    Showalter, Timothy N.
    BRACHYTHERAPY, 2014, 13 (05) : 502 - 507
  • [35] Toxicity and risk factors after combined high-dose-rate brachytherapy and external beam radiation therapy in men ≥75 years with localized prostate cancer
    Loeser, Anastassia
    Beyer, Burkhard
    Carl, Cedric Oliver
    Loeser, Benjamin
    Nagaraj, Yamini
    Frenzel, Thorsten
    Petersen, Cordula
    Kruell, Andreas
    Graefen, Markus
    Schwarz, Rudolf
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (05) : 374 - 382
  • [36] Time-driven activity-based costing of a novel form of CT-guided high-dose-rate brachytherapy intraoperative radiation therapy compared with conventional breast intraoperative radiation therapy for early stage breast cancer
    Suralik, Greg
    Rudra, Sonali
    Dutta, Sunil W.
    Yu, Jialu
    Sanders, Jason C.
    Schad, Michael D.
    Janowski, Einsley-Marie
    Su, Lucy
    Libby, Bruce
    Showalter, Shayna L.
    Lobo, Jennifer M.
    Showalter, Timothy N.
    BRACHYTHERAPY, 2020, 19 (03) : 348 - 354
  • [37] Health-related quality of life and rates of toxicity after high-dose-rate brachytherapy in combination with external beam radiation therapy for high-risk prostate cancer
    Huang-Tiel, Hui-Juan
    Otto, Isabella
    Golka, Klaus
    Selinski, Silvia
    Koswig, Stephan
    Bathe, Kathrin
    Hallmann, Steffen
    Ecke, Thorsten H.
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (03) : 250 - 259
  • [38] Predictors of poor cosmesis in breast cancer patients treated with adjuvant whole breast radiation therapy plus high-dose-rate interstitial brachytherapy boost after breast conservation surgery
    Feizi, Nasim
    Arvandi, Shole
    Feli, Maryam
    Mohammadian, Fatemeh
    Zahiri, Ziba
    Shamsi, Azin
    Bagheri, Ali
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2022, 14 (05) : 429 - 437
  • [39] Toxicity and risk factors after combined high-dose-rate brachytherapy and external beam radiation therapy in men ≥75 years with localized prostate cancer; [Toxizität und Risikofaktoren nach kombinierter Hochdosis-Brachytherapie und perkutaner Bestrahlung bei Männern ≥75 Jahren mit lokalisiertem Prostatakarzinom]
    Löser A.
    Beyer B.
    Carl C.O.
    Löser B.
    Nagaraj Y.
    Frenzel T.
    Petersen C.
    Krüll A.
    Graefen M.
    Schwarz R.
    Strahlentherapie und Onkologie, 2019, 195 (5) : 374 - 382